Teva Pharmaceutical Launches First Generic Formulation of Gilead's Blockbuster Antiretroviral Truvada
Teva's Budding Blockbuster Drugs Lend Respite From Legal Concerns - Bloomberg
With appeals court win, Takeda scores blockbuster Velcade patent reprieve till 2022 | Fierce Pharma
Teva Is Easy Pill to Swallow - WSJ
Teva Pharmaceuticals considers laying-off 10,000 workers - The Jerusalem Post
After Multiple Failures, Teva Returns Laquinimod Rights to Active Biotech | BioSpace
EU antitrust authorities launch probe of Teva over Copaxone drug | The Times of Israel
Teva Pharmaceuticals to lay off 14,000 employees worldwide, 1,750 in Israel - The Jerusalem Post
Sex, drugs, and sharing trade secrets
Generic-drug maker Teva steals market share from Big Pharma - Aug. 5, 2009
Teva eyes Asian expansion - Pharmaceutical Technology
Teva reports jump in first-quarter earnings, raises guidance | The Times of Israel
Teva Finally Wins FDA Approval for Potential Huntington's Blockbuster Austedo | BioSpace
Migraine treatment results in Japan boost Teva - Globes
Teva, the world's largest generic drugmaker, is cutting 14,000 workers - Los Angeles Times
Teva Pharmaceutical Stock Could Double | Barron's
Israel's Teva to move US HQ from Pennsylvania to New Jersey | The Times of Israel
Teva Pharmaceuticals - Generic and Specialty Pharmaceuticals | Start-Up Nation Finder
Generics distributor Anda, Inc. has a new owner: Teva Pharma
Meet The New Teva: 8% Global Generics Share, 300 ANDAs, 1,500 Launches :: Scrip
Allergan sells generic drug unit to Israel's Teva for $40.5 billion - Los Angeles Times
Teva Pharmaceutical Industries is in talks to manufacture and distribute COVID vaccines | Fortune
Teva Pharmaceutical Shares Plunge After Quarterly Loss and 2018 Outlook Warning - WSJ
Teva banks on blockbuster Austedo sales as COVID-19, Copaxone generics take their toll | Fierce Pharma
New branded drugs helping Teva Pharm move closer to growth | Reuters
Sandoz and Teva invalidate blockbuster apixaban patent and SPC - JUVE Patent
